NEW YORK (Reuters Health) – A new test makes feasible the early detection of Turner syndrome, according to a report in the December 8 issue of The Journal…
NEW YORK (Reuters Health) – There’s no need for people to stop taking aspirin before an immunochemical fecal occult blood test (iFOBT) because it won’t hamper the performance…
NEW YORK (Reuters Health) – Conjugated bilirubin (CB) and direct bilirubin (DB) level measurements cannot be interpreted interchangeably, caution a group of pediatricians from San Francisco, California in…
NEW YORK (Reuters Health) – The common practice of routinely testing patients with ischemic stroke for inherited thrombophilias can do more harm than good, according to a new…
NEW YORK (Reuters Health) – In order to minimize the risk of potential harms, erythropoiesis-stimulating agents (ESAs) in patients undergoing myelosuppressive chemotherapy should be administered at the lowest…
NEW YORK (Reuters Health) – The reported sensitivity of numerous blood-based markers proposed for the early detection of colorectal cancer (CRC) are probably higher than might be expected…
NEW YORK (Reuters Health) – Senior investigator Dr. Henry T. Akinbi of Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, provided this perspective in…
NEW YORK (Reuters Health) – When sepsis is suspected in a newborn infant, a complete blood count as a test for infection improves “dramatically” with increasing time over…
NEW YORK (Reuters Health) – The percentage of cardiac surgery patients given blood transfusions varies widely from center to center, but a conservative use of transfusions is not…
NEW YORK (Reuters Health) – Trauma patients transfused with ABO-compatible plasma have a higher rate of complications such as sepsis and renal failure than patients given ABO-identical plasma,…